Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A
- 1 April 1992
- journal article
- case report
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 1 (1), 29-33
- https://doi.org/10.1038/ng0492-29
Abstract
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited peripheral neuropathy in humans, characterized electrophysiologically by decreased nerve conduction velocities (NCVs). CMT1A is associated with a large submicroscopic DNA duplication in proximal 17p. In this report we demonstrate that a patient with a cytogenetically visible duplication, dup(17)(p11.2p12), has decreased NCV. Molecular analysis demonstrated this patient was duplicated for all the DNA markers duplicated in CMT1A as well as markers both proximal and distal to the CMT1A duplication. These data support the hypothesis that the CMT1A phenotype can result from a gene dosage effect.Keywords
This publication has 15 references indexed in Scilit:
- De novo duplication of 17p [dup(17)(p12→p11.2)]: Report of an additional case with confirmation of the cytogenetic, phenotypic, and developmental aspectsAmerican Journal of Medical Genetics, 1991
- Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2Genomics, 1991
- Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)Neuromuscular Disorders, 1991
- Localization of a locus for Charcot-Marie-Tooth neuropathy type la (CMT1A) to chromosome 17Genomics, 1990
- A genetic map of human chromosome 17pGenomics, 1990
- Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17Experimental Neurology, 1989
- A mapped set of DNA markers for human chromosome 17Genomics, 1988
- De novo partial duplication of 17p [dup(17)(p12→p11.2)]: Clinical reportAmerican Journal of Medical Genetics, 1986
- De novo tandem duplication 17p11->cenJournal of Medical Genetics, 1983
- Genetic and clinical aspects of Charcot‐Marie‐Tooth's diseaseClinical Genetics, 1974